nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol valerate/Dienogest—CYP3A4—Rifampicin—leprosy	0.403	0.548	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Dapsone—leprosy	0.332	0.452	CbGbCtD
Estradiol valerate/Dienogest—Mood alteration NOS—Thalidomide—leprosy	0.03	0.113	CcSEcCtD
Estradiol valerate/Dienogest—Dementia—Thalidomide—leprosy	0.0147	0.0554	CcSEcCtD
Estradiol valerate/Dienogest—Erythema nodosum—Thalidomide—leprosy	0.0139	0.0526	CcSEcCtD
Estradiol valerate/Dienogest—Galactorrhoea—Thalidomide—leprosy	0.00929	0.035	CcSEcCtD
Estradiol valerate/Dienogest—Metrorrhagia—Thalidomide—leprosy	0.00844	0.0318	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Dapsone—leprosy	0.00724	0.0273	CcSEcCtD
Estradiol valerate/Dienogest—Acne—Thalidomide—leprosy	0.00716	0.027	CcSEcCtD
Estradiol valerate/Dienogest—Jaundice cholestatic—Thalidomide—leprosy	0.00686	0.0259	CcSEcCtD
Estradiol valerate/Dienogest—Hypocalcaemia—Thalidomide—leprosy	0.00658	0.0248	CcSEcCtD
Estradiol valerate/Dienogest—Pulmonary embolism—Thalidomide—leprosy	0.00603	0.0227	CcSEcCtD
Estradiol valerate/Dienogest—Cramps of lower extremities—Thalidomide—leprosy	0.00554	0.0209	CcSEcCtD
Estradiol valerate/Dienogest—Thrombophlebitis—Thalidomide—leprosy	0.00505	0.0191	CcSEcCtD
Estradiol valerate/Dienogest—Libido decreased—Thalidomide—leprosy	0.00472	0.0178	CcSEcCtD
Estradiol valerate/Dienogest—Visual disturbance—Thalidomide—leprosy	0.00462	0.0174	CcSEcCtD
Estradiol valerate/Dienogest—Purpura—Thalidomide—leprosy	0.00454	0.0171	CcSEcCtD
Estradiol valerate/Dienogest—Cerebrovascular accident—Thalidomide—leprosy	0.00447	0.0168	CcSEcCtD
Estradiol valerate/Dienogest—Disturbance in sexual arousal—Thalidomide—leprosy	0.00434	0.0164	CcSEcCtD
Estradiol valerate/Dienogest—Migraine—Thalidomide—leprosy	0.00431	0.0162	CcSEcCtD
Estradiol valerate/Dienogest—Mood swings—Thalidomide—leprosy	0.00415	0.0156	CcSEcCtD
Estradiol valerate/Dienogest—Breast disorder—Thalidomide—leprosy	0.00395	0.0149	CcSEcCtD
Estradiol valerate/Dienogest—Cramp muscle—Thalidomide—leprosy	0.00394	0.0149	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal distension—Thalidomide—leprosy	0.00381	0.0144	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Thalidomide—leprosy	0.00371	0.014	CcSEcCtD
Estradiol valerate/Dienogest—Weight increased—Thalidomide—leprosy	0.00344	0.013	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Dapsone—leprosy	0.00344	0.013	CcSEcCtD
Estradiol valerate/Dienogest—Weight decreased—Thalidomide—leprosy	0.00342	0.0129	CcSEcCtD
Estradiol valerate/Dienogest—Depression—Thalidomide—leprosy	0.00336	0.0127	CcSEcCtD
Estradiol valerate/Dienogest—Acute coronary syndrome—Thalidomide—leprosy	0.00332	0.0125	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Dapsone—leprosy	0.00332	0.0125	CcSEcCtD
Estradiol valerate/Dienogest—Myocardial infarction—Thalidomide—leprosy	0.00331	0.0125	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Thalidomide—leprosy	0.00292	0.011	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Thalidomide—leprosy	0.00286	0.0108	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Thalidomide—leprosy	0.00283	0.0107	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Thalidomide—leprosy	0.00281	0.0106	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Thalidomide—leprosy	0.00273	0.0103	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Dapsone—leprosy	0.00267	0.0101	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Thalidomide—leprosy	0.00265	0.01	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Thalidomide—leprosy	0.00264	0.00994	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Dapsone—leprosy	0.00263	0.00992	CcSEcCtD
Estradiol valerate/Dienogest—Flatulence—Thalidomide—leprosy	0.0026	0.00979	CcSEcCtD
Estradiol valerate/Dienogest—Tension—Thalidomide—leprosy	0.00259	0.00975	CcSEcCtD
Estradiol valerate/Dienogest—Nervousness—Thalidomide—leprosy	0.00256	0.00965	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Thalidomide—leprosy	0.00253	0.00955	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Dapsone—leprosy	0.0025	0.00941	CcSEcCtD
Estradiol valerate/Dienogest—Angioedema—Thalidomide—leprosy	0.00241	0.00908	CcSEcCtD
Estradiol valerate/Dienogest—Palpitations—Thalidomide—leprosy	0.00233	0.00878	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Thalidomide—leprosy	0.00224	0.00843	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Thalidomide—leprosy	0.00215	0.00811	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Thalidomide—leprosy	0.00211	0.00795	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Thalidomide—leprosy	0.00189	0.00714	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Thalidomide—leprosy	0.00186	0.007	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Thalidomide—leprosy	0.00185	0.00699	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Thalidomide—leprosy	0.00184	0.00694	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Thalidomide—leprosy	0.00176	0.00663	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Thalidomide—leprosy	0.00171	0.00644	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Thalidomide—leprosy	0.0017	0.00641	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Thalidomide—leprosy	0.00158	0.00598	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Thalidomide—leprosy	0.00154	0.00582	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Thalidomide—leprosy	0.00152	0.00574	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Thalidomide—leprosy	0.00142	0.00536	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Thalidomide—leprosy	0.00137	0.00516	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Thalidomide—leprosy	0.00136	0.00511	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Thalidomide—leprosy	0.00135	0.00511	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Thalidomide—leprosy	0.00135	0.00508	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Thalidomide—leprosy	0.00128	0.00482	CcSEcCtD
